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was strongly suspected because of the patient’s typical 
mucocutaneous lesions. Therefore, targeted genetic testing 
for the endoglin and ACVRL1 genes should be performed 
to establish an early diagnosis if there are characteristic 
cutaneous features and/or a family history of HHT.
The cutaneous stigmata, which are characterized by an ac-
cumulation of small-caliber and superficial vessels, can 
cause cosmetic concerns and a risk for bleeding1,2,5. In our 
case, treatment with pulsed dye laser resulted in dramatic 
improvement of the skin lesions, similar to results reported 
by Halachmi et al.2. Multiple treatments and follow-up vis-
its can be necessary because of the lower response of 
HHT than non-HHT telangiectasia and the possible accu-
mulation of new vascular lesions2.
In conclusion, to initially rule out an HHT diagnosis, ge-
netic study is an available option. Because of the super-
ficial nature of vascular lesions, shorter wavelength vas-
cular lasers such as the pulsed dye laser can be consid-
ered an effective and safe treatment option for HHT. 
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Dear Editor:
Fried et al.1 reported on a specific disease entity using the 
term “Pretibial lymphoplasmacytic plaque in children”.
Herein, we describe a 3-year-old girl with a 6-month his-
tory of a solitary, asymptomatic, erythematous, scaly pla-
que with some papules over the right knee (Fig. 1A). She 
had a clean medical history with no history of travel 
abroad, injury, or insect bite. The biopsy specimen was 
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Table 1. Previously reported cases showing the same findings with lymphoplasmacytic plaque in children
　Study Gender/age 
(yr)
Ethnicity Location Duration Clinical appearance Treatment
Gilliam et al.5* F/15 Caucasian Pretibial 11 years 4.5 cm reddish brown 
violaceous plaque
Pulse-dye laser with partial 
improvement of the color
M/7 Caucasian Pretibial 2 years Cluster of dark reddish 
brown papulonodules
Fried et al.1 F/11 Caucasian Pretibial 5 years 4.0 cm reddish brown 
plaque
Intralesional steroid injections with 
partial remission
Ahn et al.2* F/7 Asian Buttock 7 years 3.0 cm erythematous 
scaly plaque
Topical application of methylpred-
nisolone acetate and tacrolimus 
hydrate and intralesional steroid 
injections with partial remission 
Eventually treated with excision
Moulonguet
  et al.3
F/5 Caucasian Pretibial 10 months 3.5 cm reddish scaly 
plaque
Topicalsteroids (Clobetasol under 
occlusion) with slight improvement
M/11 North 
  African
Pretibial 1 year 3.0 cm reddish scaly 
plaque
Topical steroids with slight 
improvement
Porto et al.4 F/17 Caucasian Thigh ＞10 years 2.0 cm pink 
serpiginousplaque
Excision and recurrence free
F/2 Caucasian 3rd finger 2 years 8 mm erythematous 
scalyplaque
Observe the lesion while weighing 
treatment options
Present case F/3 Asian Knee 6 months 2.5 cm reddish scaly 
plaque
Topical steroids (0.3% Diflucortolone 
valerate ointment) with unsuccessful 
response and no change in size for 
a year
F: female, M: male. *Published with another diagnosis, isolated benign primary cutaneous plasmacytosis.
Fig. 1. (A) Solitary reddish scaly 
plaque on the right knee. (B) Punch 
biopsy shows dense inflammatory 
infiltrate in lichenoid arrangement 
with perivascular and periadenxal 
extension into the deep dermis 
(H&E, ×40). (C) Higher magnifica-
tion revealing the infiltrate is com-
posed of numerous plasma cells 
admixed with lymphocytes (H&E, 
×400).
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characterized by focal parakeratosis, irregular acanthosis, 
and dense dermal lymphoid infiltrates, admixed with nu-
merous plasma cells. The plasma cells extended into the 
deep dermis with a perivascular and periadnexal pattern, 
as previously reported by Ahn et al.2. The specimen also 
revealed a lichenoid reaction with basal vacuolization and 
lymphoid exocytosis, similar to those reported by 
Moulonguet et al.3 and Porto et al.4 (Fig. 1B, C).
The immunohistochemical studies showed mixed in-
flammation of the B-cell and T-cell lymphocytes. Additio-
nally, a polyclonal pattern was confirmed by the co-ex-
istence of kappa and lambda light chain-positive cells. No 
organisms were identified on the acid fast bacilli, Giemsa, 
and periodic acid-Schiff staining. A serologic test for syph-
ilis and the QuantiFERON-TB Gold (Cellestis Limited, 
Carnegie, Australia) test both yielded negative results.
Lymphoplasmacytic plaque (LPP) was originally termed 
“isolated benign primary cutaneous plasmacytosis in chil-
dren,” as it was thought to be a part of the spectrum of pri-
mary cutaneous plasmacytosis (PCP)5. Several similar cas-
es, which have been reported as LPP or under a different 
diagnosis, shared common clinical features including a 
solitary plaque with a predilection for the lower legs and 
prevalence in the pediatric age group4. These features 
were distinct from those of PCP, which is characterized by 
multiple red-brown plaques located on the trunk, mainly 
in adult Asian patients1. These previously reported cases, 
which we believe represent LPP, are described in Table 1.
Histopathologically, LPP exhibited an irregular acanthosis 
with overlying parakeratosis and dermal lymphoplasma-
cytic infiltrates, with or without epitheloid granulomas. 
The localized inflammation and epidermal hyperplasia 
may contribute to the papulosquamous morphology of 
LPP. Clinically, the plaque seemed to be a benign chronic 
condition, although there was no effective treatment other 
than complete excision (Table 1).
Moulonguet et al.3 differentiated LPP from acral pseudo-
lymphomatous angiokeratoma of children, suggesting that 
these disease entities may reside on the spectrum of 
pseudolymphomas. Pseudolymphomas can develop after 
exposure to certain antigens. Interestingly, the histological 
pattern of a lichenoid inflammation with periadnexal in-
filtrate was very similar to those of lichen striatus, except 
for the heavy composition of plasma cells that is important 
for the diagnosis of LPP. Therefore, given the similarities 
in the age of onset and the histologic findings, we believe 
both conditions could be caused by a local reaction to an 
unknown, acquired stimulus in a specific age group. 
In conclusion, although the pathophysiology is still un-
known, LPP is a unique disease entity with typical clinical 
features. When a child presents with this type of plaque 
on the lower extremities, several disease entities including 
primary lymphoproliferative disorders, infectious lesions, 
other reactive infiltrates, or pseudolymphomas need to be 
considered. A final punch biopsy is necessary to confirm 
the diagnosis.
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